Cytomx Therapeutics Stock Price on August 30, 2024
| CTMX Stock | USD 1.07 0.06 5.31% |
Below is the normalized historical share price chart for CytomX Therapeutics extending back to October 08, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of CytomX Therapeutics stands at 1.07, as last reported on the 29th of December, with the highest price reaching 1.16 and the lowest price hitting 1.06 during the day.
If you're considering investing in CytomX Stock, it is important to understand the factors that can impact its price. CytomX Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0161, which signifies that the company had a -0.0161% return per unit of risk over the last 3 months. CytomX Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CytomX Therapeutics' Standard Deviation of 4.13, insignificant risk adjusted performance, and Mean Deviation of 3.12 to double-check the risk estimate we provide.
At this time, CytomX Therapeutics' Liabilities And Stockholders Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 709.7 M in 2024, despite the fact that Total Stockholder Equity is likely to grow to (45.1 M). . Price Earnings To Growth Ratio is likely to rise to 2.12 in 2024, whereas Price To Sales Ratio is likely to drop 1.07 in 2024. CytomX Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of October 2015 | 200 Day MA 1.4904 | 50 Day MA 1.0641 | Beta 1.061 |
CytomX |
Sharpe Ratio = -0.0161
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CTMX |
Estimated Market Risk
| 4.18 actual daily | 37 63% of assets are more volatile |
Expected Return
| -0.07 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CytomX Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CytomX Therapeutics by adding CytomX Therapeutics to a well-diversified portfolio.
Price Book 5.0363 | Enterprise Value Ebitda 3.8585 | Price Sales 0.6613 | Shares Float 66.5 M | Wall Street Target Price 5.286 |
Related Headline
Spero Therapeutics Headline on 30th of August 2024
Acquisition by Esther Rajavelu of 300000 shares of Spero The... by Esther Rajavelu
Filed transaction by Spero Therapeutics Officer See Remarks. Grant, award or other acquisition pursuant to Rule 16b-3
CytomX Therapeutics Valuation on August 30, 2024
It is possible to determine the worth of CytomX Therapeutics on a given historical date. On August 30, 2024 CytomX was worth 1.16 at the beginning of the trading date compared to the closed value of 1.18. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of CytomX Therapeutics stock. Still, in general, we apply an absolute valuation method to find CytomX Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of CytomX Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against CytomX Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.16 | 1.18 | 1.14 | 1.15 | 296,568 | |
08/30/2024 | 1.16 | 1.18 | 1.14 | 1.18 | 208,924 |
| 1.17 | 1.20 | 1.12 | 1.12 | 280,486 |
| Backtest CytomX Therapeutics | | | CytomX Therapeutics History | | | CytomX Therapeutics Valuation | Previous | Next |
CytomX Therapeutics Trading Date Momentum on August 30, 2024
| On September 03 2024 CytomX Therapeutics was traded for 1.12 at the closing time. The top price for the day was 1.20 and the lowest listed price was 1.12 . The trading volume for the day was 280.5 K. The trading history from September 3, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 5.08% . The overall trading delta against the current closing price is 1.69% . |
CytomX Therapeutics Fundamentals Correlations and Trends
By evaluating CytomX Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among CytomX Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. CytomX financial account trend analysis is a perfect complement when working with valuation or volatility modules.About CytomX Therapeutics Stock history
CytomX Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CytomX is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CytomX Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CytomX Therapeutics stock prices may prove useful in developing a viable investing in CytomX Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 73.8 M | 48.9 M | |
| Net Loss | -104.3 M | -109.5 M |
CytomX Therapeutics Quarterly Net Working Capital |
|
CytomX Therapeutics Stock Technical Analysis
CytomX Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
CytomX Therapeutics Period Price Range
Low | December 29, 2024
| High |
0.00 | 0.00 |
CytomX Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
CytomX Therapeutics December 29, 2024 Market Strength
Market strength indicators help investors to evaluate how CytomX Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CytomX Therapeutics shares will generate the highest return on investment. By undertsting and applying CytomX Therapeutics stock market strength indicators, traders can identify CytomX Therapeutics entry and exit signals to maximize returns
CytomX Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for CytomX Therapeutics' price direction in advance. Along with the technical and fundamental analysis of CytomX Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CytomX to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.18) | |||
| Treynor Ratio | (0.09) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for CytomX Stock Analysis
When running CytomX Therapeutics' price analysis, check to measure CytomX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CytomX Therapeutics is operating at the current time. Most of CytomX Therapeutics' value examination focuses on studying past and present price action to predict the probability of CytomX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CytomX Therapeutics' price. Additionally, you may evaluate how the addition of CytomX Therapeutics to your portfolios can decrease your overall portfolio volatility.